Press Releases
Nova's Diabetes Care Products Held Not To Infringe Roche's Claims
On July 27, 2010 The Honorable Joseph J. Farnan of the United States District Court for the District of Delaware issued an order granting client Nova Biomedical Corporation’s motion for summary judgment of non-infringement of two patents asserted by Roche Diagnostics Operations Inc. and Corange Int’l Ltd.
Read more…
Nova Biomedical Awarded Multi-Year Glucose Monitoring System Agreement With Premier, Inc.
Nova Biomedical announced it has been awarded a new multi-year glucose monitoring system agreement with Premier Purchasing Partners, the group purchasing unit of Premier, Inc.
Read more…
Nova Biomedical Awarded Multi-Year Glucose Monitoring System Agreement With HealthTrust Purchasing Group
Nova Biomedical announced it has been awarded a new multi-year glucose monitoring system agreement with HealthTrust Purchasing Group, LP (HealthTrust).
Read more…
Nova Biomedical's StatStrip® Xpress™ Glucose Meter receives FDA CLIA Waived Designation
Nova Biomedical's StatStrip® Xpress™ glucose monitor has been granted CLIA-waived status from the U.S. Food and Drug Administration.
Read more…
Nova Biomedical Corporation Triumphs in High-Stakes Trade Secret Litigation in California
Following a three-week trial, a California federal jury on Sept. 11, 2009 awarded a complete victory to Nova Biomedical Corporation against Medtronic MiniMed, Inc., which had brought claims against Nova for misappropriation of trade secrets, breach of contract, tortuous interference and conversion.
Read more…
Nova Biomedical Completes Acquisition of Assets of CCS Medical's Subsidiary, Sanvita, Inc.
Nova Biomedical Corporation, a leading developer of whole blood analyzers, today announced that the company's independent, wholly owned subsidiary, Sanvita CBGM, LLC, has completed the acquisition of certain assets of Sanvita, Inc., a subsidiary of CCS Medical, Inc.
Read more…
Nova Biomedical and CCS Medical Reach Definitive Agreement
Nova Biomedical Corporation, a leading developer of whole blood analyzers, and CCS Medical, Inc. a leading direct-to-consumer provider of medical supplies, today announced that they have reached a definitive agreement under which Nova Biomedical’s independent, wholly owned subsidiary, Sanvita CBGM, LLC, will acquire certain assets of Sanvita, Inc., a wholly-owned subsidiary of CCS Medical. Sanvita, Inc. is currently the exclusive distributor of Nova’s “NovaMax” consumer blood glucose product line in the United States. The NovaMax blood glucose monitor has the fastest test time and absolutely no coding.
Read more…
Automated Modular Analyzer Provides Fast, Comprehensive Cell Culture Analysis
A new, automated modular analyzer from Nova Biomedical provides fast, comprehensive analysis for cell culture processing. BioProfile® FLEX provides up to 15 key cell culture attributes, including glucose, lactate, glutamine, glutamate, ammonium, PCO2, PO2, pH, sodium, potassium, calcium, osmolality, cell density/viability, and phosphate in a single, easy to use workstation.
Read more…
Nova StatStrip Glucose Analyzer Receives FDA Clearance for Neonatal Testing
Nova's new StatStrip™ Glucose Monitor has received clearance from the U.S. Food and Drug Administration for use in neonatal testing.
Read more…
First True "No Coding" Blood Glucose Monitoring System Provides Fast, Convenient Solution for Diabetes Self-Testing
An advanced blood glucose monitoring system from Nova Biomedical provides a fast, convenient solution for diabetes self-testing. The newly released Nova Max™ system is built around patented* new technology test strips that are so precise they do not require the calibration or coding required of currently available blood glucose monitors to perform a glucose test.
Read more…
"All-in-One" Stat Analyzer Adds Total Bilirubin to Test Menu
Nova Biomedical announces the incorporation of total bilirubin (tBil) to the comprehensive test menu on its Stat Profile® Critical Care Xpress (CCX) "All-in-One" Analyzers.
Read more…
Point-of-Care Blood Glucose Monitoring System Measures and Correct Hematocrit and Electrochemical Interferences
An advanced blood glucose monitoring system from Nova Biomedical elevates bedside glucose testing to a new level of analytical performance that approaches the quality of central laboratory testing.
Read more…
Novation Contract Awarded to Nova Biomedical
Nova Biomedical is pleased to announce that it has been awarded a three-year agreement to provide its multi-analyte point of care testing instrumentation to Novation, effective August 1, 2005.
Read more…
StatStrip® Glucose and StatSensor™ Creatinine Meters Now Allow Off-Line Entry of POC Test Results
A new software enhancement for Nova StatStrip® Glucose and StatSensor™ Creatinine point-of-care monitoring systems allows off-line entry of POC test results for immediate data capture.
Read more…
OPC Connectivity Suite Facilitates BioProfile® FLEX Bi-Directional Automation and Process Integration
A new Connectivity Suite from Nova Biomedical is a complete plug and play solution for use with the BioProfile® FLEX Cell Culture Analyzer that facilitates Nova's groundbreaking bi-directional automation and product integration.
Read more…
Contract Manufacturing
Nova Biomedical Featured in Achieving Business Success Online
The ability to adapt new technologies and bring new products to the market has helped make Nova Biomedical a leader in the medical device industry...
Click here to view this article…
Diabetes Glucose Meter Receives Medical Design Award
Nova Biomedical has been recognized as a supplier to the 2004 Medical Design Excellence Awards (MDEA) winner for its contribution to the Paradigm Link™ intelligent glucose meter.
Read more…
Accelerating Speed to Market
From Concept to Finished Device, Development Efforts Can Benefit from 'Thinking Out-of-the-Box' Approach.
Click here to view this article…